The cerebrovascular effects of nimodipine are still poorly understood even in the healthy condition; in particular, its effects on tissue oxygenation have never been investigated. The aim of the present study was to investigate changes in cerebral oxygenation and blood volume upon oral administration of nimodipine (90 mg) in the healthy condition. In eight subjects, changes in cerebral tissue oxygenation and blood volume were determined simultaneously with changes in blood velocity of the middle cerebral artery (VMCA) by using, respectively, near infrared spectroscopy (NIRS) and transcranial Doppler ultrasonography (TCD). The subjects also underwent non-invasive assessment of arterial blood pressure (ABP) and end-tidal CO2. TCD and NIRS ...
Background: Early diagnosis of delayed cerebral ischemia (DCI) in patients after aneurysmal subarach...
To clarify the mechanism of its effect on ischemic stroke, we investigated the effect of nimodipine,...
Objective: Treatment of relapses in multiple sclerosis (MS) has not advanced beyond steroid use, w...
The cerebrovascular effects of nimodipine are stillpoorly understood even in the healthy condition; ...
Nimodipine shows promise in the prevention and treatment of brain ischemia. We examined the interact...
Nimodipine is a 1,4-dihydropyridine-derivative Ca(2+)-channel blocker developed approximately 30 yea...
Thirty-five patients undergoing cardiac surgery requiring cardiopu/monary bypass (CPB) were allocate...
SUMMARY Experimental subarachnoid hemorrhage (SAH) was induced in baboons by repeated injec-tions of...
Nimodipine (a dihydropyridine derivative) is one of a range of compounds which have been termed calc...
The purposes of this study were to compare the effects of the calcium entry blocker nimodipine (Bay ...
PubMedID: 11210440Excessive calcium influx has been implicated in the pathophysiology of ischemic ce...
Background: Nimodipine is routinely administered in patients with aneurysmal subarachnoid hemorrhage...
Acute cerebral hypoxia causes rapid calcium shifts leading to neuronal damage and death. Calcium cha...
We investigated the effects of intravenous application of nimodipine on the neurophysiologic, bioche...
The stainless steel cannula inserting method was used to investigate the blocking effects of nimodip...
Background: Early diagnosis of delayed cerebral ischemia (DCI) in patients after aneurysmal subarach...
To clarify the mechanism of its effect on ischemic stroke, we investigated the effect of nimodipine,...
Objective: Treatment of relapses in multiple sclerosis (MS) has not advanced beyond steroid use, w...
The cerebrovascular effects of nimodipine are stillpoorly understood even in the healthy condition; ...
Nimodipine shows promise in the prevention and treatment of brain ischemia. We examined the interact...
Nimodipine is a 1,4-dihydropyridine-derivative Ca(2+)-channel blocker developed approximately 30 yea...
Thirty-five patients undergoing cardiac surgery requiring cardiopu/monary bypass (CPB) were allocate...
SUMMARY Experimental subarachnoid hemorrhage (SAH) was induced in baboons by repeated injec-tions of...
Nimodipine (a dihydropyridine derivative) is one of a range of compounds which have been termed calc...
The purposes of this study were to compare the effects of the calcium entry blocker nimodipine (Bay ...
PubMedID: 11210440Excessive calcium influx has been implicated in the pathophysiology of ischemic ce...
Background: Nimodipine is routinely administered in patients with aneurysmal subarachnoid hemorrhage...
Acute cerebral hypoxia causes rapid calcium shifts leading to neuronal damage and death. Calcium cha...
We investigated the effects of intravenous application of nimodipine on the neurophysiologic, bioche...
The stainless steel cannula inserting method was used to investigate the blocking effects of nimodip...
Background: Early diagnosis of delayed cerebral ischemia (DCI) in patients after aneurysmal subarach...
To clarify the mechanism of its effect on ischemic stroke, we investigated the effect of nimodipine,...
Objective: Treatment of relapses in multiple sclerosis (MS) has not advanced beyond steroid use, w...